- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Lana K. Varney
News 4 results
Recognition
August 21, 2020
The Best Lawyers in America Recognizes 128 King & Spalding Lawyers in its 2021 Guide
Recognition
August 16, 2019
The Best Lawyers in America Recognizes 115 King & Spalding Lawyers in its 2020 Guide
Press Release
August 15, 2018
Best Lawyers in America Recognizes Over 100 King & Spalding Lawyers in 2019 Rankings
Press Release
April 24, 2017
King & Spalding’s Austin Office Adds Three Tort Litigation Partners
Events 3 results
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Conference
September 5, 2019
12th Annual Medical Device Summit
Speaking Engagement
November 28, 2018
Andy Bayman, Lana Varney to Speak at ACI’s Annual Conference on Drug & Medical Device Litigation
Insights 3 results
Client Alert
October 6, 2020
FDA Announces Updates to Two Guidance Documents Concerning Breast Implant Safety and Transparency
Client Alert
September 1, 2020
FDA Continues its Focus on Breast Implant Safety and Transparency with an Eye Toward Improving Regulatory Decision-Making
Article · Source: In-House Defense Quarterly
September 21, 2018
Defending Your Client’s Confidential Documents in the Big Data Age